Computational toxicology in drug development
Authors:
- Wolfgang MusterWMWolfgang Muster
- Alexander BreidenbachABAlexander Breidenbach
- Holger FischerHFHolger Fischer
- Stephan KirchnerSKStephan Kirchner
- Lutz MüllerLMLutz Müller
- Axel PählerAPAxel Pähler
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (7-8) , 303-310
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to AneuploidyMolecular and Cellular Biology, 2007
- The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1Current Biology, 2007
- Calmodulin Antagonist W‐7 Prevents Sparfloxacin‐Induced Early Afterdepolarizations (EADs) in Isolated Rabbit Purkinje Fibers: Importance of Beat‐to‐Beat Instability of the RepolarizationJournal of Cardiovascular Electrophysiology, 2006
- Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?Toxicologic Pathology, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Endothelin-1–Induced Cardiac Hypertrophy Is Inhibited by Activation of Peroxisome Proliferator–Activated Receptor-α Partly Via Blockade of c-Jun NH 2 -Terminal Kinase PathwayCirculation, 2004
- Trends in ion channel drug discovery: advances in screening technologiesTrends in Biotechnology, 2003
- From Crystal Structures and Their Analysis to the in silico Prediction of Toxic PhenomenaHelvetica Chimica Acta, 2003
- Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUSStructure, 2003
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997